Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical firms, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use – and failure to perform so may be grounds for compensation. Our lawyers are operating challenging to obtain those hurt by the drug the compensation they are entitled to.
While bleeding can be a widespread complication connected with anticoagulants, it has been alleged that Xarelto is more unsafe than conventional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, inside the event of an emergency, patients might be at danger for irreversible bleeding issues, including life-threatening internal and gastrointestinal hemorrhaging.
In the event you or a loved one particular suffered a critical bleeding event after taking Xarelto, you may have legal recourse. For more details, speak to us today to have your case reviewed, free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in cases of death, funeral expenditures. In addition, they may be in search of punitive damages, that are usually awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.
Visit this page for a lot more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.